1-(Thiophen-2-yl)butan-1-one
Common Name: |
1-(Thiophen-2-yl)butan-1-one |
IUPAC Name: |
1-thiophen-2-ylbutan-1-one |
Molecular Formula: |
C8H10OS |
SMILES: |
CCCC(=O)C1=CC=CS1 |
Inchi: |
1S/C8H10OS/c1-2-4-7(9)8-5-3-6-10-8/h3,5-6H,2,4H2,1H3 |
Inchi Key: |
YXHIINNJOGKPLF-UHFFFAOYSA-N |
Cas No: |
5333-83-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
154.23 |
Mass (g/mol) |
154.045 |
Molar Refractivity |
44.13 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
3 |
Rings |
1 |
TPSA |
45.31 |
Hetero Atoms |
2 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
5 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
242.00 to 244.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.028 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.38 |
LogP |
2.731 |
iLOGP |
2.24 |
XLOGP3 |
1.32 |
WLOGP |
2.73 |
MLOGP |
1.43 |
ESOL Log S |
-1.80 |
ESOL Solubility (mg/ml) |
2.45 |
ESOL Solubility (mol/l) |
0.016 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.87 |
Ali Solubility (mg/ml) |
2.07 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.80 |
Silicos-IT Solubility (mg/ml) |
0.25 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.30 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.868 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.83 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |